BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 6500367)

  • 1. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
    Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
    Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
    Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
    Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Superinfection with delta agent in chronic carriers of HBsAg in Spain. Clinical, epidemiologic and virologic characteristics].
    Bas L; Carreño V; Porres JC; Mora I; Gutiez J; de Torres M; Hernández Guio C
    Rev Clin Esp; 1984 Oct; 175(2):67-9. PubMed ID: 6522725
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
    Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
    J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers.
    Arico S; Aragona M; Rizzetto M; Caredda F; Zanetti A; Marinucci G; Diana S; Farci P; Arnone M; Caporaso N
    Lancet; 1985 Aug; 2(8451):356-8. PubMed ID: 2862515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
    Rizzetto M; Purcell RH; Gerin JL
    Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.
    Rizzetto M; Shih JW; Gocke DJ; Purcell RH; Verme G; Gerin JL
    Lancet; 1979 Nov; 2(8150):986-90. PubMed ID: 91776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of delta infection on severity of hepatitis B.
    Smedile A; Farci P; Verme G; Caredda F; Cargnel A; Caporaso N; Dentico P; Trepo C; Opolon P; Gimson A; Vergani D; Williams R; Rizzetto M
    Lancet; 1982 Oct; 2(8305):945-7. PubMed ID: 6127458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of cell and serum immunologic markers in chronic persistent or active hepatitis B.
    Picciotto A; Crovari P; Cuneo Crovari P; De Flora S; Dodero M; Celle G
    J Med Virol; 1981; 8(3):195-200. PubMed ID: 7328423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
    Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
    Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of delta infection.
    Moestrup T; Hansson BG; Widell A; Nordenfelt E
    Br Med J (Clin Res Ed); 1983 Jan; 286(6359):87-90. PubMed ID: 6401506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers.
    Hadziyannis SJ; Sherman M; Lieberman HM; Shafritz DA
    Hepatology; 1985; 5(4):544-7. PubMed ID: 4018727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic delta hepatitis: a difficult problem for the hepatologist.
    Picciotto A; Celle G
    Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of delta infection in the western Pacific region.
    Dimitrakakis M; Crowe S; Gust I
    J Med Virol; 1986 Apr; 18(4):335-9. PubMed ID: 3011980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus DNA (HBV-DNA) in anti-HBe positive sera.
    Negro F; Chiaberge E; Oliviero S; Hammer M; Berninger M; Canese MG; Bonino F
    Liver; 1984 Jun; 4(3):177-83. PubMed ID: 6748873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A possible misdiagnosis in patients presenting with acute HBsAg-negative hepatitis: the role of hepatitis delta virus.
    Caredda F; Antinori S; Pastecchia C; Coppin P; Arici C; Fracassetti O
    Infection; 1988; 16(6):358-9. PubMed ID: 3220581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.